Isto Technologies

About

ISTO Technologies is an orthobiologics firm developing biologic products to regenerate and restore function to damaged cartilage and bone.

51 - 100

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $1.20M
Industries: Biotechnology,Information Technology,Medical Device
Founded date: Jan 1, 1997
Number Of Employee: 51 - 100
Operating Status: Close

ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$1.95M

Isto Technologies has raised a total of $1.95M in funding over 2 rounds. Their latest funding was raised on Jul 29, 2015 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 29, 2015	Grant	$1.20M	1	—	—	Detail
Aug 14, 2002	Grant	$750K	1	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

5

0

Isto Technologies has made 5 investments. Their most recent investment was on May 25, 2022, when Finnt raised $3.50M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
May 25, 2022 Finnt	Seed	$3.50M	Cryptocurrency	—
Mar 2, 2022 Polymer Labs	Seed	$3.60M	Blockchain	—
Jun 9, 2021 Eight Sleep	Angel	—	Consumer Electronics	—
Apr 1, 2021 Goody	Series A	$13.10M	Consumer	—
Mar 10, 2021 Clara	Pre-seed	$3.50M	Credit Cards	—